Oncore Pharma Signs European Marketing Deal for Colorectal Cancer Test
The seven-gene test, ColonSentry, is designed to determine an individual's current risk for colorectal cancer relative to an average risk population.
GeneNews, Oncore Pharma Ink Colorectal Cancer Test Deal
Oncore and its partners will commercialize GeneNews' ColonSentry test in all countries outside the US and Canada under the five-year exclusive agreement
GeneNews Posts 88 Percent Decline in Q2 Revenues; Inks Liquid Biopsy Alliance With LifeX
The company has struck a deal to market its tests, including ones based on its Aristotle early cancer detection platform, in collaboration with LifeX.
GeneNews Partners With AIM Laboratories on Cancer Tests
The companies have signed a deal under which each will make its tests available to the other's customer base.
GeneNews Q1 Revenues Plummet Amid Billing Changes
The company had to halt and later restart billing for its cancer risk assessment tests as it transitioned to a new billing process.